Jefferies Financial Group Inc. Insmed Inc Call Options Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$22.0 - $69.71 $48,400 - $153,362
2,200 Added 41.51%
7,500 $502,000
Q1 2024

May 13, 2024
BUY
$25.72 - $29.94 $56,584 - $65,868
2,200 Added 70.97%
5,300 $143,000
Q4 2023

Feb 13, 2024
BUY
$23.42 - $31.74 $2,342 - $3,174
100 Added 3.33%
3,100 $96,000
Q3 2023

Nov 14, 2023
BUY
$19.86 - $26.93 $59,580 - $80,790
3,000 New
3,000 $75,000

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email